These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3514676)

  • 1. Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion.
    Bray GL; Thompson AR
    J Clin Invest; 1986 Apr; 77(4):1194-200. PubMed ID: 3514676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intragenic deletion of the factor IX gene in a family with hemophilia B.
    Chen SH; Yoshitake S; Chance PF; Bray GL; Thompson AR; Scott CR; Kurachi K
    J Clin Invest; 1985 Dec; 76(6):2161-4. PubMed ID: 3001143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor IX antigen by radioimmunoassay. Abnormal factor IX protein in patients on warfarin therapy and with hemophilia B.
    Thompson AR
    J Clin Invest; 1977 May; 59(5):900-10. PubMed ID: 856873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders.
    Bray GL; Weinmann AF; Thompson AR
    J Lab Clin Med; 1986 Mar; 107(3):269-78. PubMed ID: 3485164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleotide substitutions at the -6 position in the promoter region of the factor IX gene result in different severity of hemophilia B Leyden: consequences for genetic counseling.
    Vidaud D; Tartary M; Costa JM; Bahnak BR; Gispert-Sanchez S; Fressinaud E; Gazengel C; Meyer D; Goossens M; Lavergne JM
    Hum Genet; 1993 Apr; 91(3):241-4. PubMed ID: 8478007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA analysis of seven patients with hemophilia B who have anti-factor IX antibodies: relationship to clinical manifestations and evidence that the abnormal gene was inherited.
    Tanimoto M; Kojima T; Kamiya T; Takamatsu J; Ogata K; Obata Y; Inagaki M; Iizuka A; Nagao T; Kurachi K
    J Lab Clin Med; 1988 Sep; 112(3):307-13. PubMed ID: 3411192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A de novo intragenic deletion of the potential EGF domain of the factor IX gene in a family with severe hemophilia B.
    Vidaud M; Chabret C; Gazengel C; Grunebaum L; Cazenave JP; Goossens M
    Blood; 1986 Oct; 68(4):961-3. PubMed ID: 2875754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor IX Chongqing: a new mutation in the calcium-binding domain of factor IX resulting in severe hemophilia B.
    Wang NS; Zhang M; Thompson AR; Chen SH
    Thromb Haemost; 1990 Feb; 63(1):24-6. PubMed ID: 2339358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency).
    Peake IR; Furlong BL; Bloom AL
    Lancet; 1984 Feb; 1(8371):242-3. PubMed ID: 6142993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients.
    Matthews RJ; Anson DS; Peake IR; Bloom AL
    J Clin Invest; 1987 Mar; 79(3):746-53. PubMed ID: 3029178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.
    Chen SH; Thompson AR; Zhang M; Scott CR
    J Clin Invest; 1989 Jul; 84(1):113-8. PubMed ID: 2472424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX.
    Schach BG; Yoshitake S; Davie EW
    J Clin Invest; 1987 Oct; 80(4):1023-8. PubMed ID: 2821070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemophilia B caused by five different nondeletion mutations in the protease domain of factor IX.
    Ludwig M; Sabharwal AK; Brackmann HH; Olek K; Smith KJ; Birktoft JJ; Bajaj SP
    Blood; 1992 Mar; 79(5):1225-32. PubMed ID: 1346975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier testing in hemophilia B with an immunoassay that distinguishes a prevalent factor IX dimorphism.
    Smith KJ; Thompson AR; McMullen BA; Frazier D; Lin SW; Stafford D; Kisiel W; Thibodeau SN; Chen SH; Smith LF
    Blood; 1987 Oct; 70(4):1006-13. PubMed ID: 3651597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular studies of haemophilia B in Sweden. Identification of patients with total deletion of the factor IX gene and without inhibitory antibodies.
    Wadelius C; Blombäck M; Pettersson U
    Hum Genet; 1988 Dec; 81(1):13-7. PubMed ID: 2848757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemophilia B in a female.
    Shetty S; Ghosh K; Mohanty D
    Acta Haematol; 2001; 106(3):115-7. PubMed ID: 11713376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete deletion of factor IX gene and inhibition of factor IX activity in a labrador retriever with hemophilia B.
    Brooks MB; Gu W; Ray K
    J Am Vet Med Assoc; 1997 Dec; 211(11):1418-21. PubMed ID: 9394892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.
    Furutani H
    Medinfo; 1995; 8 Pt 2():909. PubMed ID: 8591581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of hemophilia B by an immunoradiometric assay of factor IX.
    Holmberg L; Gustavii B; Cordesius E; Kristoffersson AC; Ljung R; Löfberg L; Strömberg P; Nilsson IM
    Blood; 1980 Sep; 56(3):397-401. PubMed ID: 7407407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of canine factor IX.
    Sugahara Y; Catalfamo J; Brooks M; Hitomi E; Bajaj SP; Kurachi K
    Thromb Haemost; 1996 Mar; 75(3):450-5. PubMed ID: 8701406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.